Eyler Phillip

Director Eyler Phillip bought 8,300 shares of SNBR at $9.03 amid cluster buy; stock down -56.5% from 52-week high, company unprofitable.

Director Eyler Phillip purchased 8,300 shares at $9.03, increasing his holdings from 12,672 to 20,972 shares (a 65.5% increase), as two other insiders also bought within the past 14 days, suggesting coordinated confidence. Sleep Number's fundamentals remain stressed: the company posted net income of $-8.6M on revenue of $393.3M, with annual revenue growth of -10.9%, and the stock trades at $8.87—down 56.5% from its 52-week high of $20.41. The 30-day recovery of +76.3% provides a near-term price context, but the 90-day decline of -49.4% reflects persistent pressure. This cluster buy by multiple insiders at depressed levels warrants monitoring to assess whether management's buying signals a fundamental turnaround or is simply a response to valuation alone.

CEO Eyler sells 29.7K THRM shares at $42.31; holds 147.3K post-sale; stock -26.7% from 52-week high.

Eyler Phillip (President & CEO) sold 29,684 shares for $1,255,930.04 on 2024-11-21, reducing his holdings by 16.8% to 147,317 shares. This is his sixth open-market sale of THRM in the past four months (also sold on 2024-09-19, 2024-09-18, 2024-09-17, 2024-08-06, and 2024-07-11), indicating a sustained pattern of share disposition. His prior five sales at THRM show strong timing outcomes: all resulted in negative 30-day and 90-day returns, with 2 of 2 measurable 90-day outcomes (from August and July) showing declines of -12.2% and -15.7% respectively, consistent with well-timed sell execution. The stock is currently at $43.38, down -26.7% from its $59.18 52-week high but up 7.6% over the last 30 days. Company fundamentals remain solid (revenue $371.5M, +22.0% YoY growth, P/E 19.81), but the CEO's continued reduction of ownership at depressed valuations within this 52-week range deserves monitoring for any material developments not yet disclosed.

THRM CEO Eyler sells 15,000 shares (15.0K) across 3 days for $752,790.98 at $50.19 avg

Phillip Eyler, President & CEO of Gentherm Inc, executed 3 separate sales totaling 15,000 shares for $752,790.98 between September 17–19, 2024, reducing his holdings from 162,317 to 147,317 shares (-9.2%). The trades were executed near the 52-week high of $59.18 (current price $50.78 is -14.2% from that peak), and at a blended average price of $50.19. The company's fundamentals show positive growth (revenue +22.0% annually, $375.7M latest quarter) with a P/E of 23.51, suggesting the stock was not trading at distressed levels at the time of sale. His prior THRM sales show a 2-of-3 well-timed rate at the 90-day mark, and his cross-ticker track record reports 85.71% well-timed sell rate across 9 prior dispositions, though this filing's post-execution price performance cannot yet be fully assessed within traditional measurement windows.

THRM CEO Phillip sold 15,000 shares at $50.03; stock now -23.0% from 52-week high, down 3.0% over 90 days.

Phillip sold 15,000 shares (9.2% of his pre-transaction holdings) at $50.03, leaving him with 147,317 shares. This is his second sell in less than a month at THRM—he previously sold on 2024-07-11 and 2024-06-05 (twice). His cross-ticker track record shows 8 prior open-market sells with a 90-day well-timed rate of 80.00%, suggesting disciplined exit discipline historically. At THRM specifically, his prior sells show mixed outcomes: two June sales declined 9.9% and 10.8% over 30 days (consistent with downside timing), but a May sale gained 6.9% in 30 days before rising another 0.7% by day 90. The stock is currently -23.0% from its 52-week high and has fallen 3.0% over the last 90 days, trading at $49.85 versus his $50.03 sale price. The series of sales within a concentrated timeframe warrants investor attention to whether the CEO perceives deteriorating momentum or is executing a structured reduction in a company that has grown revenue 22.0% annually.

GENTHERM CEO Eyler sells 15,000 shares at $50.40; stock down 22.4% from 52-week high, recent declines offset prior THRM sell timing edge

Phillip Eyler, President & CEO of GENTHERM Inc, sold 15,000 shares (-9.2% of holdings) at $50.40 on 2024-07-11 for $756,000.00. The transaction occurs while the stock is -22.4% from its 52-week high and has declined 3.3% over the past 30 days and 1.2% over 90 days. His prior trades at THRM show 2 of 2 sells were well-timed at the 90-day mark; however, recent activity presents a contrasting pattern: two consecutive sales on 2024-06-05 posted -9.9% and -10.8% returns within 30 days, while an earlier May sale turned positive at +6.9% 30-day return. Against this mixed recent record at THRM and the company's strong fundamentals (annual revenue growth +22.0%, market cap $1.6B), this sale warrants observation to determine whether the timing discipline evident in his prior THRM exits persists.